Correlation Between Alto Neuroscience, and SHUAA Partners

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alto Neuroscience, and SHUAA Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alto Neuroscience, and SHUAA Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alto Neuroscience, and SHUAA Partners Acquisition, you can compare the effects of market volatilities on Alto Neuroscience, and SHUAA Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alto Neuroscience, with a short position of SHUAA Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alto Neuroscience, and SHUAA Partners.

Diversification Opportunities for Alto Neuroscience, and SHUAA Partners

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Alto and SHUAA is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and SHUAA Partners Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SHUAA Partners Acqui and Alto Neuroscience, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alto Neuroscience, are associated (or correlated) with SHUAA Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SHUAA Partners Acqui has no effect on the direction of Alto Neuroscience, i.e., Alto Neuroscience, and SHUAA Partners go up and down completely randomly.

Pair Corralation between Alto Neuroscience, and SHUAA Partners

If you would invest  1,072  in SHUAA Partners Acquisition on November 5, 2024 and sell it today you would earn a total of  0.00  from holding SHUAA Partners Acquisition or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.41%
ValuesDaily Returns

Alto Neuroscience,  vs.  SHUAA Partners Acquisition

 Performance 
       Timeline  
Alto Neuroscience, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Alto Neuroscience, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Alto Neuroscience, displayed solid returns over the last few months and may actually be approaching a breakup point.
SHUAA Partners Acqui 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SHUAA Partners Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, SHUAA Partners is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Alto Neuroscience, and SHUAA Partners Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alto Neuroscience, and SHUAA Partners

The main advantage of trading using opposite Alto Neuroscience, and SHUAA Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alto Neuroscience, position performs unexpectedly, SHUAA Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SHUAA Partners will offset losses from the drop in SHUAA Partners' long position.
The idea behind Alto Neuroscience, and SHUAA Partners Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Correlations
Find global opportunities by holding instruments from different markets